European Life Science Tools and Reagents Market
Report Scope
This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.
Report Includes
This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.
Report Includes
- 33 data tables and 54 additional tables
- An analysis of the European market for life science tools and reagents, including COVID-19 diagnostics products
- Analyses of the market trends, with historic market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the market for life science tools and reagents, with market share analysis by product, application, and country
- Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
- Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
- Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Merck KGaA, Qiagen and Roche
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Overview
Product Development in Life Science
CHAPTER 3 MARKET DYNAMICS
Global Market Dynamics
Market Drivers
Increasing Investments in R&D
Increasing Prevalence of Chronic Diseases
Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
Growth in Genomic and Biomarker Research
Increasing Demand for Personalized Medicine
Technological Advances
Market Restraints
End of COVID-19 Pandemic
High Cost of Instruments
Lack of Skilled Personnels
Market Challenges
Regulatory Hurdles
Market Opportunities
Positive Impact from Some Revisions in Pharmaceutical Legislation
New Technologies
CHAPTER 4 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Overview
Next-Generation Therapeutics
Next-Generation Diagnostics
Digitalization
AI and Machine Learning
Internet of Things (IoT)
Robots in Life Science Labs
CHAPTER 5 MARKET SEGMENTATION ANALYSIS
Overview
Segmentation Breakdown
European Market for Life Science Tools and Diagnostics, by Product Type
COVID-19 Diagnostic Tests Market
Market for Life Science Tools and Reagents
European Market for Life Science Tools and Diagnostics, by Application
Genomics
Proteomics
Cell Biology, Antibodies and Recombinant Proteins
Stem Cells Research
Imaging Tools and Techniques
Animal Models
Epigenetics
Metabolomics
Other Applications
Europe
United Kingdom
Germany
France
Switzerland
Spain
Italy
Rest of Europe
CHAPTER 6 COMPETITIVE INTELLIGENCE
PCR Technologies and Reagents
Antibodies
ELISA Instruments
ELISA Kits and Assays
Life Science Kits and Assays
COVID-19 Diagnostics
Strategic Initiatives
Recent Product Introductions in the Market
CHAPTER 7 SUSTAINABILITY IN LIFE SCIENCE TOOLS AND REAGENTS IN THE EUROPEAN MARKET: AN ESG PERSPECTIVE
Introduction to ESG
ESG Practices in the Industry
Status of ESG in the Industry
Concluding Remarks from BCC
CHAPTER 8 APPENDIX
Methodology
Acronyms
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Overview
Product Development in Life Science
CHAPTER 3 MARKET DYNAMICS
Global Market Dynamics
Market Drivers
Increasing Investments in R&D
Increasing Prevalence of Chronic Diseases
Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
Growth in Genomic and Biomarker Research
Increasing Demand for Personalized Medicine
Technological Advances
Market Restraints
End of COVID-19 Pandemic
High Cost of Instruments
Lack of Skilled Personnels
Market Challenges
Regulatory Hurdles
Market Opportunities
Positive Impact from Some Revisions in Pharmaceutical Legislation
New Technologies
CHAPTER 4 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Overview
Next-Generation Therapeutics
Next-Generation Diagnostics
Digitalization
AI and Machine Learning
Internet of Things (IoT)
Robots in Life Science Labs
CHAPTER 5 MARKET SEGMENTATION ANALYSIS
Overview
Segmentation Breakdown
European Market for Life Science Tools and Diagnostics, by Product Type
COVID-19 Diagnostic Tests Market
Market for Life Science Tools and Reagents
European Market for Life Science Tools and Diagnostics, by Application
Genomics
Proteomics
Cell Biology, Antibodies and Recombinant Proteins
Stem Cells Research
Imaging Tools and Techniques
Animal Models
Epigenetics
Metabolomics
Other Applications
Europe
United Kingdom
Germany
France
Switzerland
Spain
Italy
Rest of Europe
CHAPTER 6 COMPETITIVE INTELLIGENCE
PCR Technologies and Reagents
Antibodies
ELISA Instruments
ELISA Kits and Assays
Life Science Kits and Assays
COVID-19 Diagnostics
Strategic Initiatives
Recent Product Introductions in the Market
CHAPTER 7 SUSTAINABILITY IN LIFE SCIENCE TOOLS AND REAGENTS IN THE EUROPEAN MARKET: AN ESG PERSPECTIVE
Introduction to ESG
ESG Practices in the Industry
Status of ESG in the Industry
Concluding Remarks from BCC
CHAPTER 8 APPENDIX
Methodology
Acronyms
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
LIST OF TABLES
Summary Table : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 1 : Differences Between Basic and Applied Research
Table 2 : Pharmaceutical Industry R&D Expenditures in Europe, by Select Countries, 2022
Table 3 : Cancer Cases in Europe for Both Sexes, 2022
Table 4 : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 5 : European Market for COVID-19 Diagnostics Tests, by Type, Through 2029
Table 6 : European Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 7 : European Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 8 : European Market for COVID-19 Serological Tests, by Country, Through 2029
Table 9 : European Market for Life Science Tools and Reagents, by Type, Through 2029
Table 10 : European Market for Life Science Instruments, by Country, Through 2029
Table 11 : European Market for Life Science Reagents and Kits, by Country, Through 2029
Table 12 : European Market for Life Science Tools and Reagents, by Application, Through 2029
Table 13 : European Market for Genomics, by Country, Through 2029
Table 14 : Drug Targets Identified by Proteomics
Table 15 : European Market for Proteomics, by Country, Through 2029
Table 16 : European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 17 : European Market for Stem Cell Research, by Country, Through 2029
Table 18 : European Market for Imaging Tools and Techniques, by Country, Through 2029
Table 19 : European Market for Animal Models, by Country, Through 2029
Table 20 : European Market for Epigenetics, by Country, Through 2029
Table 21 : European Market for Metabolomics, by Country, Through 2029
Table 22 : European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 23 : European Based Companies’ R&D Expenditures and Comparison of Their Net Sales, 2023
Table 24 : European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 25 : European Market for Life Science COVID-19 Diagnostics Tests, by Country, Through 2029
Table 26 : Ranking of Life Science Tool and Reagent Companies in Europe, 2023
Table 27 : Leading Providers of PCR Technologies, by Revenue, 2023
Table 28 : Leading Suppliers of Research Antibodies, 2023
Table 29 : Leading Providers of ELISA Instruments/Microplate Readers, 2023
Table 30 : Leading Providers of ELISA Kits and Assays, 2023
Table 31 : Ranking of Leading Suppliers of Kits and Assays, 2023
Table 32 : Ranking of Leading Providers of COVID-19 Diagnostics Tools, 2023
Table 33 : Collaborations in the Life Science Tools and Reagents Market, 2020–2024
Table 34 : Mergers and Acquisitions in the Life Science Tools and Reagents Market, 2021-2024
Table 35 : Recent New Life Science Tools and Reagents, 2021–2024
Table 36 : Key Focus Areas in ESG Metrics
Table 37 : Environmental Initiatives by Various Life Science Tools, Reagents and Diagnostics Companies and Some of their Initiatives in Europe
Table 38 : Key Social and Governance Issues in the Life Science Tools, Reagents and Diagnostics Industry
Table 39 : ESG Rankings for Companies in the Life Science Tools and Reagents Market, 2023
Table 40 : Glossary of Terms Used in This Report
Table 41 : Information Sources in This Report
Table 42 : Agilent Technologies Inc.: Company Snapshot
Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44 : Agilent Technologies Inc.: Product Portfolio
Table 45 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 46 : Altona Diagnostic GmbH.: Company Snapshot
Table 47 : Altona Diagnostic GmbH: Product Portfolio
Table 48 : Altona Diagnostic GmbH: News/Key Developments, 2021-2023
Table 49 : Analytik Jena GmbH+Co KG: Company Snapshot
Table 50 : Analytik Jena GmbH+Co KG: Product Portfolio
Table 51 : Analytik Jena GmbH+Co KG: News/Key Developments, 2023
Table 52 : BD: Company Snapshot
Table 53 : BD: Financial Performance, FY 2022 and 2023
Table 54 : BD: Product Portfolio
Table 55 : BD: News/Key Developments, 2021-2024
Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
Table 60 : Danaher Corp.: Company Snapshot
Table 61 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 62 : Danaher Corp.: Product Portfolio
Table 63 : Danaher Corp.: News/Key Developments, 2021-2023
Table 64 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 65 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 66 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 67 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021–2023
Table 68 : Merck KGaA: Company Snapshot
Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70 : Merck KGaA.: Product Portfolio
Table 71 : Merck KGaA: News/Key Developments, 2021-2024
Table 72 : Promega Corp.: Company Snapshot
Table 73 : Promega Corp.: Product Portfolio
Table 74 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 75 : Qiagen: Company Snapshot
Table 76 : Qiagen: Financial Performance, FY 2022 and 2023
Table 77 : Qiagen: Product Portfolio
Table 78 : Qiagen: News/Key Developments, 2023
Table 79 : Revvity Inc.: Company Snapshot
Table 80 : Revvity Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Revvity Inc.: Product Portfolio
Table 82 : Revvity Inc.: News/Key Developments, 2023 and 2024
Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024
Summary Table : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 1 : Differences Between Basic and Applied Research
Table 2 : Pharmaceutical Industry R&D Expenditures in Europe, by Select Countries, 2022
Table 3 : Cancer Cases in Europe for Both Sexes, 2022
Table 4 : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 5 : European Market for COVID-19 Diagnostics Tests, by Type, Through 2029
Table 6 : European Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 7 : European Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 8 : European Market for COVID-19 Serological Tests, by Country, Through 2029
Table 9 : European Market for Life Science Tools and Reagents, by Type, Through 2029
Table 10 : European Market for Life Science Instruments, by Country, Through 2029
Table 11 : European Market for Life Science Reagents and Kits, by Country, Through 2029
Table 12 : European Market for Life Science Tools and Reagents, by Application, Through 2029
Table 13 : European Market for Genomics, by Country, Through 2029
Table 14 : Drug Targets Identified by Proteomics
Table 15 : European Market for Proteomics, by Country, Through 2029
Table 16 : European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 17 : European Market for Stem Cell Research, by Country, Through 2029
Table 18 : European Market for Imaging Tools and Techniques, by Country, Through 2029
Table 19 : European Market for Animal Models, by Country, Through 2029
Table 20 : European Market for Epigenetics, by Country, Through 2029
Table 21 : European Market for Metabolomics, by Country, Through 2029
Table 22 : European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 23 : European Based Companies’ R&D Expenditures and Comparison of Their Net Sales, 2023
Table 24 : European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 25 : European Market for Life Science COVID-19 Diagnostics Tests, by Country, Through 2029
Table 26 : Ranking of Life Science Tool and Reagent Companies in Europe, 2023
Table 27 : Leading Providers of PCR Technologies, by Revenue, 2023
Table 28 : Leading Suppliers of Research Antibodies, 2023
Table 29 : Leading Providers of ELISA Instruments/Microplate Readers, 2023
Table 30 : Leading Providers of ELISA Kits and Assays, 2023
Table 31 : Ranking of Leading Suppliers of Kits and Assays, 2023
Table 32 : Ranking of Leading Providers of COVID-19 Diagnostics Tools, 2023
Table 33 : Collaborations in the Life Science Tools and Reagents Market, 2020–2024
Table 34 : Mergers and Acquisitions in the Life Science Tools and Reagents Market, 2021-2024
Table 35 : Recent New Life Science Tools and Reagents, 2021–2024
Table 36 : Key Focus Areas in ESG Metrics
Table 37 : Environmental Initiatives by Various Life Science Tools, Reagents and Diagnostics Companies and Some of their Initiatives in Europe
Table 38 : Key Social and Governance Issues in the Life Science Tools, Reagents and Diagnostics Industry
Table 39 : ESG Rankings for Companies in the Life Science Tools and Reagents Market, 2023
Table 40 : Glossary of Terms Used in This Report
Table 41 : Information Sources in This Report
Table 42 : Agilent Technologies Inc.: Company Snapshot
Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44 : Agilent Technologies Inc.: Product Portfolio
Table 45 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 46 : Altona Diagnostic GmbH.: Company Snapshot
Table 47 : Altona Diagnostic GmbH: Product Portfolio
Table 48 : Altona Diagnostic GmbH: News/Key Developments, 2021-2023
Table 49 : Analytik Jena GmbH+Co KG: Company Snapshot
Table 50 : Analytik Jena GmbH+Co KG: Product Portfolio
Table 51 : Analytik Jena GmbH+Co KG: News/Key Developments, 2023
Table 52 : BD: Company Snapshot
Table 53 : BD: Financial Performance, FY 2022 and 2023
Table 54 : BD: Product Portfolio
Table 55 : BD: News/Key Developments, 2021-2024
Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
Table 60 : Danaher Corp.: Company Snapshot
Table 61 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 62 : Danaher Corp.: Product Portfolio
Table 63 : Danaher Corp.: News/Key Developments, 2021-2023
Table 64 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 65 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 66 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 67 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021–2023
Table 68 : Merck KGaA: Company Snapshot
Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70 : Merck KGaA.: Product Portfolio
Table 71 : Merck KGaA: News/Key Developments, 2021-2024
Table 72 : Promega Corp.: Company Snapshot
Table 73 : Promega Corp.: Product Portfolio
Table 74 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 75 : Qiagen: Company Snapshot
Table 76 : Qiagen: Financial Performance, FY 2022 and 2023
Table 77 : Qiagen: Product Portfolio
Table 78 : Qiagen: News/Key Developments, 2023
Table 79 : Revvity Inc.: Company Snapshot
Table 80 : Revvity Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Revvity Inc.: Product Portfolio
Table 82 : Revvity Inc.: News/Key Developments, 2023 and 2024
Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024
LIST OF FIGURES
Summary Figure : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, 2021-2029
Figure 1 : Market Dynamics of European Life Science Tools and Reagents Market
Figure 2 : New Diagnostic Techniques
Figure 3 : Comparison of New Active Substances Approvals
Figure 4 : Comparison of European Patent Applications and Granted Patents, by Technical Field, 2011-2022
Figure 5 : European Market Shares of COVID-19 Diagnostics Tests, by Type, 2023
Figure 6 : European Market Shares of Life Science Tools and Reagents, by Type, 2023
Figure 7 : Types of ELISA
Figure 8 : Firms and R&D Investment in Health Industries, 2012 and 2022
Figure 9 : Pharmaceutical Pipeline Activity and Key Therapeutic Areas in Europe, 2022
Figure 10 : The U.K. Market for Life Science Tools and Reagents, 2024-2029
Figure 11 : German Market for Life Science Tools and Reagents, 2021-2029
Figure 12 : French Market for Life Science Tools and Reagents, 2021-2029
Figure 13 : Swiss Market for Life Science Tools and Reagents, 2024-2029
Figure 14 : Spanish Market for Life Science Tools and Reagents, 2024-2029
Figure 15 : Italian Market for Life Science Tools and Reagents, 2021-2029
Figure 16 : Rest of the European Market for Life Science Tools and Reagents, 2021-2029
Figure 17 : EPFIA’s Environmental Sustainability Measures
Figure 18 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 19 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 20 : BD: Revenue Share, by Business Unit, FY 2023
Figure 21 : BD: Revenue Share, by Country/Region, FY 2023
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 28 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 29 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 30 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 31 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 32 : Revvity Inc.: Revenue Share, by Business Unit, FY 2023
Figure 33 : Revvity Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Summary Figure : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, 2021-2029
Figure 1 : Market Dynamics of European Life Science Tools and Reagents Market
Figure 2 : New Diagnostic Techniques
Figure 3 : Comparison of New Active Substances Approvals
Figure 4 : Comparison of European Patent Applications and Granted Patents, by Technical Field, 2011-2022
Figure 5 : European Market Shares of COVID-19 Diagnostics Tests, by Type, 2023
Figure 6 : European Market Shares of Life Science Tools and Reagents, by Type, 2023
Figure 7 : Types of ELISA
Figure 8 : Firms and R&D Investment in Health Industries, 2012 and 2022
Figure 9 : Pharmaceutical Pipeline Activity and Key Therapeutic Areas in Europe, 2022
Figure 10 : The U.K. Market for Life Science Tools and Reagents, 2024-2029
Figure 11 : German Market for Life Science Tools and Reagents, 2021-2029
Figure 12 : French Market for Life Science Tools and Reagents, 2021-2029
Figure 13 : Swiss Market for Life Science Tools and Reagents, 2024-2029
Figure 14 : Spanish Market for Life Science Tools and Reagents, 2024-2029
Figure 15 : Italian Market for Life Science Tools and Reagents, 2021-2029
Figure 16 : Rest of the European Market for Life Science Tools and Reagents, 2021-2029
Figure 17 : EPFIA’s Environmental Sustainability Measures
Figure 18 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 19 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 20 : BD: Revenue Share, by Business Unit, FY 2023
Figure 21 : BD: Revenue Share, by Country/Region, FY 2023
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 28 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 29 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 30 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 31 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 32 : Revvity Inc.: Revenue Share, by Business Unit, FY 2023
Figure 33 : Revvity Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
